All News

The staff at Pharmaceutical Representative hit the bookstores looking for some of the most interesting sales, business and finance titles this season. Here's what we found.

An increasing number of physicians in the United States are choosing to practice in medical group settings, according to a study published by the AMA.

New drug treatments are offering hope to patients who suffer from autism, compulsive buying and hypochondria, according to one expert in the field.

Patients and professionals who want more information on breast cancer have a new resource on the Internet's World Wide Web.

Two researchers have published new guidelines for managed care systems to evaluate drug products.

Not long after the Olympic athletes took their medals home from Atlanta last summer, one area pharmaceutical company won another kind of competition.

Pharmaceutical Representative recently asked members of its Reader Advisory Panel to describe their new year's resolutions. If you're thinking about making a resolution, these examples may give you some good ideas.

FDA Commissioner David Kessler, M.D., is leaving after six years at the agency

Pharmaceutical Representative recently asked industry experts to predict the future. The following are their responses about the coming year.

We asked top intellectual property lawyers about what the Supreme Courts decision will mean for pharma and biotech companies. Here is our forward-looking analysis of their comments.